Platelet-Rich Plasma Market, By Product (Pure PRP, Leukocyte Rich PRP, and Leukocyte Rich Fibrin), A

Published Date: May 2020 | Report Code : HC2067948

X

Platelet-Rich Plasma Market, By Product (Pure PRP, Leukocyte Rich PRP, and Leukocyte Rich Fibrin), Application (Orthopedics, Cosmetic Surgery & Dermatology, Ophthalmic Surgery, Neurosurgery, General surgery, and Others) And By Region (North America, Europe, Asia Pacific, Middle East & Africa, And South America) – Market Size & Forecasting To 2028

COVID-19 Impact : Our team has been closely monitoring the current developments to identify the potential impact of COVID-19 on stakeholders and business processes across the value chain of industries. A special section about COVID-19 will be covered with the report to help companies in defining sustainable strategies.

Domain : Healthcare

Report Code : HC2067948

Status : Published May 2020

The Global Platelet-Rich Plasma Market size was valued at USD 423.87 million in 2019 and is anticipated to grow at a CAGR of 12.46% during the forecast period. The platelet rich plasma majorly used to relief pain by helping long lasting healing of musculoskeletal conditions and it is used for treatment of arthritis, tendonitis, ligament sprain and tear and to accelerate the healing of injured tendons, ligaments, muscles and joints.

Factors driving the global platelet-rich plasma market growth includes growing geriatric population, rise in incidence of sports and orthopedic injuries, rise in number of cosmetic surgical procedures. Moreover, Ongoing development of for hair restoration treatment, vampire facelift, and erectile dysfunction and other applications are expected to offer lucrative growth opportunities for the global platelet-rich plasma market during the forecast period. However, the high cost as USD 200 to USD 800, based on the application area is expected to hamper the global platelet-rich plasma market growth during the forecast period.

Key Factors Impacting the Growth of Platelet-Rich Plasma Market:

  • Rising demand for plasma therapy in therapeutic areas
  • Emergence of advanced platelet rich plasma technologies making it possible to care injuries
  • Increasing geriatric population and rising orthopedic conditions
  • Increasing investments to spread awareness regarding plasma therapy
  • Increase in number of sports surgeries

The platelet-rich plasma market segmentation is based on product, application, and region.

Product Outlook:

Based on product the global platelet-rich plasma market is divided into pure PRP, leukocyte rich PRP, and leukocyte rich fibrin. Pure PRP eliminates red blood cells and neutrophils and low price of PRP as average price of PRP injections starts from US$ 200 to US$ 800 compared to available counterparts thus is leading the market growth of product segment.

For Application Outlook:

Based on application, the platelet-rich plasma market has been segmented into orthopedics, cosmetic surgery & dermatology, ophthalmic surgery, neurosurgery, general surgery, and others.

The cosmetic surgery & demography segment with increasing demand for new cell growth, improve complexion, skin texture, and restore lost facial volume is expected to register the highest growth rate in the global platelet-rich plasma market during the forecast period.

Regional Outlook:

The regional breakdown includes global platelet-rich plasma market estimation and analysis of the global platelet-rich plasma market by North America, Europe, Asia Pacific, Middle East & Africa, and  South America. The North America region includes countries like US, Canada, and Mexico. Europe region includes countries like Germany, Russia, UK, France, Italy, Spain, and others. Asia Pacific region includes countries like China, Japan, India, South Korea, Australia, and others. The Middle East region includes countries like UAE, Saudi Arabia, Qatar, South Africa, and others. South America includes Brazil, Argentina, Colombia, Rest of South America.

In terms of revenue, North America is expected to dominate the global platelet-rich plasma market growth during the forecast period due to the increasing applications of platelet rich plasma in therapeutics and increasing number of people suffering from orthopedic disorders. Europe region with Increase in the number of orthopedic patients, increasing need to reduces injury healing time in orthopedic diseases and high prevalence rate of the orthopedic diseases, coupled with increasing preference for PRP therapy all over the region is expected to register substantial growth rate in the global platelet-rich plasma market during the forecast period.

Asia Pacific region is expected to register strong growth rate in the global platelet-rich plasma market during the forecast period. This growth is owing to the increasing number of cosmetic surgeries to enhance facial features in this region.

The report analyzes factors affecting the platelet-rich plasma market from both demand and supply side and further analyses market dynamics affecting the market during the forecast year such as driver, restrain, opportunities and future trends. The report also provides comprehensive Porter’s model analysis on the platelet-rich plasma market for all six regions namely; North America, Europe, Asia Pacific, Middle East & Africa and South America.

Competitive Landscape

Major companies operating in the global platelet-rich plasma market are concentrating on launch of new products, and partnerships & collaborative agreements with other companies. The leading companies in the market include Arthrex, Inc., Zimmer Biomet, Harvest Technologies Corporation, DePuy Synthes, Inc., Stryker Corporation, AdiStem Ltd., ISTO Biologics, Cesca Therapeutics, Inc., Exactech Inc., Nuo Therapeutics, and among others.

This report also includes the profiles of key Platelet-rich plasma market companies along with their SWOT analysis and market strategies. In addition, these competitive landscapes provide a detailed description of each company including future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launch, new product developments, and other latest industrial developments.

Key Developments in Platelet-Rich Plasma Market:

  • In 2020, EmCyte Corporation provider of Platelet Rich Plasma and Progenitor Stem Cell Biologics, acquired the Cellmedix Holdings, including the Centrepid Platelet Concentrator system, with the aim to expand intellectual property profile and product development capabilities.
  • In 2020, Aesthetics Biomedical, Inc. provider of an aesthetic innovation company uniquely offering procedure, product enhancement, development, clinical indication expansion, acquired the US Patent for Biologic Preserving Composition and Methods of Use.
  • In August 2017, Cesca Therapeutics, Inc. working in the development of automated technologies for cell-based therapeutics and bio-processing come into a distribution agreement with Boyalife WSN Ltd. for sale and marketing of its bio-banking and point-of-care solutions in China, India, Singapore, and the Philippines.
  • In January 2015, NuMale Medical Center one f the leading private medical clinic that offers a wide selection of the most trusted therapies for male sexual dysfunction and enhancement achieved the milestone of platelet-rich plasma treatment by treating its 3,000th patient for sexual dysfunction.

 What Does This Report Provide?

This report provides a detailed understanding of the global platelet-rich plasma market from qualitative and quantitative perspectives during the forecast period. The report also provides dynamic indicators with potential impact on the market during the forecast period and an in-depth analysis of the leading companies operating in the market.

Market Segmentation:

By Product

  • Pure PRP
  • Leukocyte Rich PRP
  • Leukocyte Rich Fibrin

 By Application

  • Orthopedics
  • Cosmetic Surgery & Dermatology
  • Ophthalmic Surgery
  • Neurosurgery
  • General surgery
  • Others

By Region:

  • North America
    • By Country (US, Canada, Mexico)
    • By Product
    • By Application
  • Western Europe
    • By Country (Germany, Russia, UK, France, Italy, Spain, Rest of Western Europe)
    • By Product
    • By Application
  • Asia Pacific
    • By Country (China, Japan, India, South Korea, Australia, Rest of Asia Pacific)
    • By Product
    • By Application
  • Middle East & Africa
    • By Country (UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa)
    • By Product
    • By Application
  • South America
    • By Country (Brazil, Argentina, Colombia, Rest of South America)
    • By Product
    • By Application

Reasons to Buy This Report:

  • Market size estimation of the platelet-rich plasma market on a regional and global basis
  • Unique research Usage for market size estimation and forecast
  • Profiling of major companies operating in the market with key developments
  • Broad scope to cover all the possible segments helping every stakeholder in the market

Customization:

We provide customization of the study to meet specific requirements:

  • By Segment
  • By Sub-segment
  • By Region/Country

For more information, contact: [email protected]

License Offering

Single User (PDF)

3850

Multi User (PDF)

5150

Enterprise User (PDF)

7650

Get Regional Report @ USD 2000 Only

Your personal details are secure. Privacy Policy

Buy Chapters of Sections

Avail customized purchase options to meet your exact research needs.

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities
Detailed Coverage

Detailed scope covering all the major segments in the market

Meticulous Data Validations

In line data validations to ensure data precision

Recommendations

Market recommendations supporting decision making processes

Analyst Support

Round the clock analyst support to resolve your queries

Free Customization

Up to 15% additional free customization to meet your specific requirements

15% Free Customization

Share your Requirements

Questions?  Speak to an Analyst

Your personal details are secure. Privacy Policy